Dr Floryne Buishand — professional profile (opens in a new tab)
Specialist surgeon & surgical oncologist; Senior Lecturer, Royal Veterinary College.
Veterinary oncology and clinical strategy
TEAM
Human medical progress. A canine mission.
Our mission is to bring the latest advances in human precision cancer care to the dogs we love. Founded in Oxford, our team combines epigenetics, AI precision medicine and veterinary science.
THE TEAM
CO-FOUNDER
Dr Ming-Shan Tsai
Oxford DPhil in Zoology, with expertise spanning epigenetics, the genetic epidemiology of animal disease and biotechnology.
CO-FOUNDER
Dr Bin Li
PhD in Biomedical Engineering and former University of Oxford postdoctoral researcher in AI precision medicine, cancer imaging, pathology and spatial biology.
BACKED BY
DEVELOPED BY SCIENTISTS FROM THE
IN COLLABORATION WITH SCIENTISTS FROM THE
DEVELOPED BY SCIENTISTS FROM THEIN COLLABORATION WITH SCIENTISTS FROM THEAdvisors
Prof Matt Kaeberlein — professional profile (opens in a new tab)
Affiliate Professor, University of Washington; co-founder of the Dog Aging Project, with 50,000+ dogs enrolled.
Aging science and longevity strategy
Dr Judy Jarecki-Black — professional profile (opens in a new tab)
Biotech Practice Head, Klintworth & Rozenblat; 20+ years in IP and former Global Head of IP at Merial.
Intellectual property and patent strategy
Dr Eleda Plouch — professional profile (opens in a new tab)
Scientific Advisor, Klintworth & Rozenblat; Emory PhD with expertise in biotechnology patents.
Biotechnology patents and scientific strategy
